These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 194517)

  • 1. Immunogenicity of tumor antigens.
    Herberman RB; Campbell DA; Oldham RK; Bonnard GD; Ting CC; Holden HT; Glaser M; Djeu J; Oehler R
    Ann N Y Acad Sci; 1976; 276():26-44. PubMed ID: 194517
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
    Wright PW; Ortiz de Landazuri M; Herberman RB
    J Natl Cancer Inst; 1973 Apr; 50(4):947-54. PubMed ID: 4574190
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR; Knight RA
    Nature; 1974 Nov; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 7. Some biologic and biochemical properties of soluble tumor antigens.
    Law LW; Appella E; Henriksen O; Rogers M
    Ann N Y Acad Sci; 1976; 276():11-25. PubMed ID: 194514
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between various cell-surface antigens induced by murine leukemia virus in the rat: serological analysis.
    Kuzumaki N; Takeichi N; Sendo F; Kodama T; Kobayashi H
    Int J Cancer; 1973 May; 11(3):575-85. PubMed ID: 4133946
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Natl Cancer Inst; 1974 Jan; 52(1):147-52. PubMed ID: 4204244
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma.
    Glaser M; Herberman R
    J Natl Cancer Inst; 1976 Jun; 56(6):1211-5. PubMed ID: 62841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological responsiveness in rats infected with the Soehner-Dmochowski murine sarcoma virus (MSV-SD).
    Evans DL; Barnett JW; Dmochowski L
    Tex Rep Biol Med; 1974; 32(2):449-60. PubMed ID: 4372740
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.